Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment
about
The impact of chronic stress on the rat brain lipidomeRodent models of depression: neurotrophic and neuroinflammatory biomarkers.Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depressionComments on Bozzatello et al. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J. Clin. Med. 2016, 5, 67.Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.Omega-6 fatty acids and greater likelihood of suicide risk and major depression in early pregnancy.On the protective effect of omega-3 against propionic acid-induced neurotoxicity in rat pups.Neurotrophins role in depression neurobiology: a review of basic and clinical evidence.Omega-3 Polyunsaturated Fatty Acids in Prevention of Mood and Anxiety Disorders.Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?Peripheral biomarkers in animal models of major depressive disorder.Targeted alterations in dietary n-3 and n-6 fatty acids improve life functioning and reduce psychological distress among patients with chronic headache: a secondary analysis of a randomized trial.The emerging role of nutrition in Parkinson's disease.Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications.Omega-3 polyunsaturated fatty acids for major depressive disorder.Contributions of animal models to the study of mood disorders.Altered neuropathic pain behaviour in a rat model of depression is associated with changes in inflammatory gene expression in the amygdala.Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research.Evidence for Inflammation-Associated Depression.Does Diet Matter? The Use of Polyunsaturated Fatty Acids (PUFAs) and Other Dietary Supplements in Inflammation-Associated Depression.ω-3 fatty acid eicosapentaenoic acid attenuates MPP+-induced neurodegeneration in fully differentiated human SH-SY5Y and primary mesencephalic cells.Simvastatin improves learning and memory in control but not in olfactory bulbectomized ratsRapamycin blocks the antidepressant effect of ketamine in task-dependent manner.Effects of eicosapentaenoic acid and docosahexaenoic acid on anxiety-like behavior in socially isolated rats.Immune effects of optimized DNA vaccine and protective effects in a MPTP model of Parkinson's disease.Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.A preliminary investigation of the effects of cognitive behavioral therapy for panic disorder on gastrointestinal distress in patients with comorbid panic disorder and irritable bowel syndrome.Maternal fish consumption during pregnancy and smoking behavioural patterns.
P2860
Q27319840-F67F667B-8BDC-4CBC-A531-848E11D97BCBQ28388439-04A5FD09-2A12-480C-87A2-25145DADA6AAQ28486258-B2F4A1A3-4791-40B4-8644-75F7117043A7Q31121789-9571123E-10DC-4028-A58B-E61B4EDB8849Q34369407-2F101570-3E70-42B0-B96D-40C502BDB372Q34553032-4BD96DF3-ACA6-4B59-AFBC-5D85F2F49883Q35206180-93643C08-18C5-4D4F-9A5F-EA2AA6D63EAFQ35687024-4F2BA322-941D-46CF-A466-04A87277EB18Q35965592-0AE3F430-6635-4BE3-BB77-2EA8C8828A72Q36075389-CFFDCD93-CFCA-4DEB-A433-B4043808C1F7Q36502629-1316AFEF-287C-48AE-998D-799D9512C540Q36709214-771F735C-D1D3-4DE1-A21E-3530C367818FQ37176590-D737C026-8652-4995-8822-44AAF57F37BDQ37251093-22B40BA9-6DC2-4759-A279-2A12EBE592DDQ37622710-452FCD45-4A9C-4486-A160-C902AE52001BQ37783637-3E87B311-8DD3-40B9-A524-25821F39AD9AQ38004705-7214E08D-47A1-448A-8036-F271969E6FBDQ38148244-5DD7AFD0-D4B3-4CA8-B5B6-D6DE6505CD5CQ38165755-5FF712C7-50E7-481A-B6B9-12232BA68E30Q38313303-3A62C3E9-004C-4C9E-B901-47C0631D9B5BQ38454097-4FCB7D1A-611D-46F5-A4FB-A32896988D5AQ38843528-37B8C1EF-B57B-4AE5-995D-820A03FE0639Q38901511-93C160E0-82E0-48F8-8093-6B3CC218381EQ39252312-E5108A09-59FC-494D-BC64-0ABB0922ACB5Q42131034-570D9217-3307-4AE6-85EE-5DA9E05B9114Q47448148-EF7E9421-F302-45E9-AEC7-5BA3DB0CA521Q47569143-09BDA6BC-5759-40C4-8F5E-040A8A451A5EQ48192125-4149D8E2-AB09-440D-B8D6-921BFC4ED049Q48234108-5702AAB3-5FD9-4A71-8BED-D3F48D4F028DQ48825700-C8EEA140-B4F3-490F-89DE-3F7846E8C6DBQ52340071-66E4D836-474C-41C6-8652-7031B7B5FD2A
P2860
Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment
description
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im Januar 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/01/07)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/01/07)
@nl
наукова стаття, опублікована в січні 2009
@uk
مقالة علمية (نشرت في 7-1-2009)
@ar
name
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@ast
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@en
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@nl
type
label
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@ast
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@en
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@nl
prefLabel
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@ast
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@en
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@nl
P2093
P3181
P1476
Increased phospholipase A2 act ...... yl-eicosapentaenoate treatment
@en
P2093
Mehar Manku
Xiang Yang Zhang
P3181
P356
10.1523/JNEUROSCI.3569-08.2009
P407
P577
2009-01-01T00:00:00Z